NDRA News and Press, ENDRA Life Sciences Inc. From 03/08/22

Endra Life Sciences (NDRA -1.6%) said the U.S. Patent and Trademark Office issued a new patent related to its Thermo Acoustic Enhanced UltraSound (TAEUS) system. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Diseas...

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), announces that the United States Patent and Trademark Office has issued ENDRA a new patent, U.S. Patent No. 11266314 (the ‘314 patent) titled “Method and ...

Phoenix, Arizona--(Newsfile Corp. - February 15, 2022) - The Stock Day Podcast welcomed ENDRA Life Sciences Inc. (NASDAQ: NDRA) ("the Company"), the pioneer of Thermo; Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at ...

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the European Patent Office (EPO) has issued two new patents to ENDRA, European Patent No. 3668382 (the ‘382 patent) titled “Method and System for Est...

New path developed in consultation with the FDA to include limited confirmatory clinical data and provide potential future competitive advantages ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), announced ...

AAP, ACTG, AESE, OTCPK:AOIFF, DADAASTS, ATHX, AXON, AYTU, BIOC, BITF, CIDM, CMP, OTCQX:CWBHF, CWBR, CWCO, CYBN, DM, DNMR, DRIO, OTCQB:ELTP, ETON, EVFM, GLAD, GNLN, GOEV, IBIO, IDEX, INPX, IONQ, ISUN, LCID, LUNA, MARK, OTCQX:MRMD, MVST, NDRA, NEPT, PLBY, POWW, PRCH, PRPO, QFIN, RKDA,...

TAEUS clinical study to serve as gateway for ENDRA into Asia’s largest healthcare market ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced it has received Institutional Review Board approval from China&...

ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, announces that management will present a company overview at the H.C. Wainwright BioConnect Virtual Conference being held January 10-13, 2022. A webcast of the presentation will be availa...

Study to Bolster Clinical Evidence of Performance of Patented TAEUS ® Ultrasound Device in NAFLD Patients as Early Product Commercialization in Europe Continues ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologie...

VGI’s Upcoming Phase 2 NAFLD-NASH study to incorporate ENDRA’s TAEUS technology to help drive trial efficiencies ENDRA Life Sciences Inc. (NASDAQ: NDRA) , a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), and VGI Health Technol...